Parkside Financial Bank & Trust’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-142
| Closed | -$26K | – | 1903 |
|
|
2021
Q2 | $26K | Buy |
142
+14
| +11% | +$2.56K | 0.01% | 699 |
|
|
2021
Q1 | $19K | Buy |
128
+2
| +2% | +$297 | 0.01% | 785 |
|
|
2020
Q4 | $19K | Buy |
126
+17
| +16% | +$2.56K | 0.01% | 737 |
|
|
2020
Q3 | $13K | Buy |
109
+45
| +70% | +$5.37K | ﹤0.01% | 769 |
|
|
2020
Q2 | $7K | Buy |
64
+28
| +78% | +$3.06K | ﹤0.01% | 879 |
|
|
2020
Q1 | $3K | Sell |
36
-33
| -48% | -$2.75K | ﹤0.01% | 1055 |
|
|
2019
Q4 | $7K | Buy |
69
+32
| +86% | +$3.25K | ﹤0.01% | 882 |
|
|
2019
Q3 | $4K | Sell |
37
-33
| -47% | -$3.57K | ﹤0.01% | 1024 |
|
|
2019
Q2 | $9K | Sell |
70
-25
| -26% | -$3.21K | ﹤0.01% | 836 |
|
|
2019
Q1 | $13K | Buy |
95
+56
| +144% | +$7.66K | ﹤0.01% | 725 |
|
|
2018
Q4 | $4K | Sell |
39
-77
| -66% | -$7.9K | ﹤0.01% | 961 |
|
|
2018
Q3 | $17K | Buy |
116
+1
| +0.9% | +$147 | 0.01% | 658 |
|
|
2018
Q2 | $14K | Sell |
115
-4
| -3% | -$487 | 0.01% | 686 |
|
|
2018
Q1 | $13K | Buy |
119
+19
| +19% | +$2.08K | ﹤0.01% | 681 |
|
|
2017
Q4 | $12K | Buy |
100
+9
| +10% | +$1.08K | ﹤0.01% | 699 |
|
|
2017
Q3 | $13K | Buy |
91
+20
| +28% | +$2.86K | 0.01% | 670 |
|
|
2017
Q2 | $8K | Sell |
71
-42
| -37% | -$4.73K | ﹤0.01% | 799 |
|
|
2017
Q1 | $13K | Buy |
113
+47
| +71% | +$5.41K | 0.01% | 642 |
|
|
2016
Q4 | $8K | Sell |
66
-31
| -32% | -$3.76K | ﹤0.01% | 759 |
|
|
2016
Q3 | $12K | Buy |
97
+92
| +1,840% | +$11.4K | 0.01% | 687 |
|
|
2016
Q2 | $1K | Sell |
5
-7
| -58% | -$1.4K | ﹤0.01% | 1030 |
|
|
2016
Q1 | $2K | Sell |
12
-21
| -64% | -$3.5K | ﹤0.01% | 938 |
|
|
2015
Q4 | $6K | Buy |
33
+8
| +32% | +$1.46K | ﹤0.01% | 757 |
|
|
2015
Q3 | $4K | Buy |
+25
| New | +$4K | ﹤0.01% | 825 |
|